| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.2 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.2 |